These products may aggravate nausea, increase heart rate, and worsen dizzinessparticularly in individuals whose appetite and caloric intake are already significantly reduced by GLP-1 medications
Combination of alpha lipoic acid and gabapentin, its efficacy in the treatment of Burning Mouth Syndrome: a randomized, double-blind, placebo controlled trial
These changes are more likely in women who are already sensitive to hormone shifts, such as those with PCOS or irregular periods
Many companies aside from Lilly and Novo Nordisk are also jumping on the train, testing their own GLP-1s in clinical trials, which could help with shortages in the future
Results The demographic and clinical data for each group are summarized in Table 1
and Cryptococcus neoformans